secwatch.observer — SEC 8-K summary
======================================

Issuer:     FOXO TECHNOLOGIES INC. (FOXO)
CIK:        0001812360
Form:       8-K
Filed at:   2025-12-16T23:59:59+00:00
Accession:  0001493152-25-027961
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FOXO CEO year-end review: revenue >$15M expected, Myrtle occupancy 93%, debt reduced
--------------------------------------------------------------------------------

- Myrtle Recovery Centers avg daily census 28 (93% occupancy) vs 7.4 (25%) in 2024; projected 550 admissions vs 195.
- Net revenues approx $12M for 9 months ended Sep 30, 2025; expects >$15M for full year 2025.
- Equity increased from $5.3M (Dec 2024) to $20.2M (Sep 2025); debt reduced from $10.2M to $7.1M.
- Acquired Vector BioSource; expects ~$1M net revenues in 2025; formed FOXO Acquisition Corp for future deals.
- Common stock lost NYSE American listing in Q3 2025 due to share price; evaluating uplisting options for 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1812360/000149315225027961/0001493152-25-027961-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1812360/000149315225027961/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-027961

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer